18 results on '"Antoine, Maud"'
Search Results
2. Synthesis and biological evaluation of 2,3-diarylimidazo[1,2-a]pyridines as antileishmanial agents
3. Synthesis and structure–activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents
4. Prévalence des effets secondaires cutanés de la radiothérapie administrée dans le traitement du cancer du sein en médecine générale
5. Discovery of (7-aryl-1,5-naphthyridin-2-yl)ureas as dual inhibitors of ERK2 and Aurora B kinases with antiproliferative activity against cancer cells
6. Elaboration of the assessment method of the conservation status of the habitat of community interest 'Coastal dunes with Juniperus spp.' (2250)
7. Efficient synthesis of novel disubstituted pyrido[3,4-b]pyrazines for the design of protein kinase inhibitors
8. Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors
9. ChemInform Abstract: A Convenient Synthesis of Novel 2,8-Disubstituted Pyrido[3,4-b]pyrazines Possessing Biological Activity.
10. A Convenient Synthesis of Novel 2,8-Disubstituted Pyrido[3,4-b]pyrazines Possessing Biological Activity
11. ChemInform Abstract: Preparation of Novel 2,3,8‐Trisubstituted Pyrido[3,4‐b]pyrazines and Pyrido[2,3‐b]pyrazines.
12. Preparation of Novel 2,3,8-Trisubstituted Pyrido[3,4-b]pyrazines and Pyrido[2,3-b]pyrazines
13. Side chain modifications of (indol-3-yl)glyoxamides as antitumor agents
14. Synthesis of New 4-(3,4,5-Trimethoxyphenyl)-3H-furo[3,4-b]carbazole-3-ones Derivatives.
15. Discovery of 7-Aryl-Substituted (1,5-Naphthyridin-4-yl)ureas as Aurora Kinase Inhibitors.
16. A Convenient Synthesis of Novel 2,8-Disubstituted Pyrido[3,4-b]pyrazines Possessing Biological Activity.
17. Preparation of Novel 2,3,8-Trisubstituted Pyrido[3,4-b]pyrazines and Pyrido[2,3-b]pyrazines.
18. Synthesis of New 4-(3,4,5-Trimethoxyphenyl)-3H-Furo[3,4-b]Carbazole-3-Ones Derivatives
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.